Literature DB >> 21400523

A multi-center study on the surgical management of metastatic disease to adrenal glands.

Andrea Valeri1, Carlo Bergamini, Fabiano Tozzi, Jacopo Martellucci, Francesco Di Costanzo, Lorenzo Antonuzzo.   

Abstract

BACKGROUND: In the management of adrenal lesions in oncological patients, many issues are still controversial: morphological signs of suspected malignancy, accuracy of imaging examinations, use of fine needle aspiration (FNA), and the role of laparoscopy. The present study attempts to address these questions through the evaluation of the management of adrenal metastases (AM) in a wide cohort of patients included in the Italian Register of Endoscopic Adrenal Surgery.
METHODS: In January 2009, all patients recorded on the Register were evaluated, on the basis of CT scan, MRI, and FNA. The diagnostic, surgical, and follow-up data of 95 patients with pre-operative AM diagnosis have been reviewed. On the basis of the fulfilled criteria three patterns were identified: "diagnostic", "suspect," and "non-diagnostic."
RESULTS: CT scan sensitivity was 41.5%/77.9% and specificity was 54.5%/90.9% for "diagnostic"/"diagnostic" + "suspect" examinations, respectively. MRI sensitivity was 15.7%/78.9% and specificity was non-determinate/83.3% for "diagnostic"/"diagnostic" + "suspect" exams, respectively. Sensitivity of FNA was 33.3%. About surgery, conversions rate was 16.6%; no mortality or re-operations were reported; complications rate was 10.7%; and no relation was noted between tumor size and surgical outcome. Mean survival was 32 months; 5-year survival was 23%, independent of AM size; survival for lung AM was similar to that of breast and kidney AM.
CONCLUSIONS: Laparoscopy for AM, in expert hand, seems to be a feasible and oncologically safe approach. Due to the unsatisfactory diagnostic accuracy for AM, every oncological patient with suspect adrenal lesions should be encouraged to undergo this surgical procedure.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21400523     DOI: 10.1002/jso.21843

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Determinants for malignancy in surgically treated adrenal lesions.

Authors:  Lucie Wright; Erik Nordenström; Martin Almquist
Journal:  Langenbecks Arch Surg       Date:  2011-09-21       Impact factor: 3.445

Review 2.  Surgical management of adrenal metastases.

Authors:  Juan J Sancho; Frédéric Triponez; Xavier Montet; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2011-12-16       Impact factor: 3.445

3.  Outcome and prognostic factors after adrenalectomy for patients with distant adrenal metastasis.

Authors:  Gina M Howell; Sally E Carty; Michaele J Armstrong; Michael T Stang; Kelly L McCoy; David L Bartlett; Linwah Yip
Journal:  Ann Surg Oncol       Date:  2013-06-21       Impact factor: 5.344

Review 4.  Adrenal metastases in lung cancer: clinical implications of a mathematical model.

Authors:  Lyudmila Bazhenova; Paul Newton; Jeremy Mason; Kelly Bethel; Jorge Nieva; Peter Kuhn
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609

5.  Laparoscopic transperitoneal lateral adrenalectomy for malignant and potentially malignant adrenal tumours.

Authors:  Michał Pędziwiatr; Mateusz Wierdak; Michał Natkaniec; Maciej Matłok; Magdalena Białas; Piotr Major; Piotr Budzyński; Alicja Hubalewska-Dydejczyk; Andrzej Budzyński
Journal:  BMC Surg       Date:  2015-08-28       Impact factor: 2.102

6.  Current concepts in the management of adrenal incidentalomas.

Authors:  Prashanth Kanagarajah; Rajinikanth Ayyathurai; Murugesan Manoharan; Govindarajan Narayanan; Bruce R Kava
Journal:  Urol Ann       Date:  2012-09

7.  Adrenal metastases - long-term results of surgical treatment, single-centre experience.

Authors:  Radosław Samsel; Andrzej Cichocki; Katarzyna Roszkowska-Purska; Lucyna Papierska; Agnieszka Koalasińska-Ćwikła; Edyta Karpeta; Tomasz Ostrowski; Karolina Nowak
Journal:  Contemp Oncol (Pozn)       Date:  2020-03-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.